 - link Copy Url
- [  Share on twitter ](https://twitter.com/intent/tweet?text=Alkermes Remains Committed to Oncology Innovation https://www.3blmedia.com/markdownify/node/382346?absolute=1&via=3blnews "link to 3 B L Media's Twitter")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/382346?absolute=1 "link to 3 B L Media's Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/382346?absolute=1 "link to 3 B L Media's Facebook")
- [ email Share via email ](mailto:?subject=Alkermes Remains Committed to Oncology Innovation&body=ESG News from Alkermes https://www.3blmedia.com/markdownify/node/382346?absolute=1 "Share via email")
 
 

 [Health &amp; Healthcare](/CSR-News/health-healthcare)

 # Alkermes Remains Committed to Oncology Innovation

 


 

 Jun 21, 2022 1:15 PM ET

  Campaign:  [Alkermes Medicines &amp; Focus: Cancer](/news/campaign/alkermes-medicines-focus-cancer)  ![](/sites/default/files/videos/thumbnails/989446/thumbnail-989446_0000.png)

 ▶ 

Video 

  

 

 



 

 

On the heels of ASCO22, we remain committed to innovating in the oncology space, particularly for cancers with high unmet needs, like platinum-resistant ovarian cancer. Thomas Herzog, M.D. and Craig Hopkinson M.D. share their insights on how our actively recruiting ARTISTRY-7 clinical trial in platinum-resistant ovarian cancer aspires to address these needs: <https://bit.ly/3azbAjw>



 

 

 

 

 

 

 

 [![Alkermes logo](/sites/default/files/Clients/alks_logo.png)](/profiles/alkermes)

 



 

### More from Alkermes

###### [Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes](/news/equal-opportunity-and-respect-diversity-inclusion-and-belonging-alkermes)

 Dec 27, 2023 11:25 AM ET

  



###### [Corporate Governance at Alkermes](/news/corporate-governance-alkermes)

 Dec 20, 2023 12:00 PM ET

  



###### [Alkermes’ Commitment to Integrity and Compliance](/news/alkermes-commitment-integrity-and-compliance)

 Dec 18, 2023 1:30 PM ET

  



###### [Alkermes’ Culture of Employee Engagement and Wellness](/news/alkermes-culture-employee-engagement-and-wellness)

 Dec 14, 2023 10:40 AM ET

  



###### [Patient Advocacy and Community Engagement at Alkermes](/news/patient-advocacy-and-community-engagement-alkermes)

 Dec 11, 2023 2:20 PM ET

  



###### [Pharmaceuticals in the Environment](/news/pharmaceuticals-environment)

 Nov 29, 2023 3:00 PM ET

  



###### [Environmental Protection &amp; Sustainability at Alkermes](/news/environmental-protection-sustainability-alkermes)

 Nov 21, 2023 11:30 AM ET

  



###### [Alkermes Celebrates #Movember for Men’s Health Awareness Month](/news/alkermes-celebrates-movember-mens-health-awareness-month)

 Nov 20, 2023 1:30 PM ET